Allergic Rhinitis
📧 Sign up to get email alerts when something new happens for Allergic Rhinitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-09-01Clinical Trial Update: Study In Adults And Adolescents With Seasonal Allergic Rhinitis [Phase 3]
A Phase 3 clinical trial in adults and adolescents with seasonal allergic rhinitis has completed.
-
FDA approval · 2016-08-25FDA Approved: TUXARIN — Supplemental Application (Mainpointe Pharmaceuticals)
FDA approved a supplemental application for TUXARIN (codeine phosphate and chlorpheniramine maleate) from Mainpointe Pharmaceuticals. The ap…
-
FDA label_change · 2016-08-23FDA Approved: ZYRTEC ALLERGY — Supplemental Application (Kenvue Brands LLC)
FDA approved a supplemental application for ZYRTEC ALLERGY (cetirizine hydrochloride) submitted by Kenvue Brands LLC, indicating a modificat…
-
FDA approval · 2016-08-12FDA Approved: CAREONE ALLERGY RELIEF — Original Application (American Sales Company)
FDA approved CAREONE ALLERGY RELIEF as an original application for cetirizine hydrochloride tablets (generic antihistamine) from American Sa…
-
CLINICAL_TRIALS trial_result · 2016-08-11Clinical Trial Update: Intralymphatic Immunotherapy (ILIT) for House Dust Mite, Cat, and Dog Allergen in Allergic Rhinitis Patients [Phase 1]
Phase 1 trial evaluating intralymphatic immunotherapy (ILIT) for house dust mite, cat, and dog allergens in allergic rhinitis patients has b…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2016-08-09FDA Approved: CLARITIN ALLERGY — Supplemental Application (Bayer HealthCare LLC.)
The FDA approved a supplemental application for Claritin Allergy (loratadine) from Bayer HealthCare LLC.
-
FDA label_change · 2016-08-09FDA Approved: CLARITIN — Supplemental Application (Bayer HealthCare LLC)
FDA approved a supplemental application for Claritin (loratadine) submitted by Bayer HealthCare LLC, indicating a labeling change for the ma…
-
FDA approval · 2016-08-05FDA Approved: CHILDRENS ALLEGRA ALLERGY — Supplemental Application (Chattem, Inc.)
The FDA approved a supplemental application for Children's Allegra Allergy (fexofenadine hydrochloride) to modify the labeling related to pe…
-
FDA approval · 2016-08-02FDA Approved: FLONASE SENSIMIST ALLERGY RELIEF — Supplemental Application (Haleon US Holdings LLC)
The FDA approved a supplemental application for Flonase Sensimist Allergy Relief containing fluticasone furoate, filed by Haleon US Holdings…
-
FDA label_change · 2016-08-01FDA Approved: ZYRTEC ALLERGY — Supplemental Application (Kenvue Brands LLC)
FDA approved a supplemental application for ZYRTEC ALLERGY (cetirizine hydrochloride) submitted by Kenvue Brands LLC. The action concerns ch…
-
CLINICAL_TRIALS research · 2016-07-15Clinical Trial Update: CARATKids: Italian Validation of Asthma and Allergic Rhinitis Control Test in Children
Italian validation study for the CARATKids questionnaire to assess control of asthma and allergic rhinitis in children.
-
CLINICAL_TRIALS trial_result · 2016-07-11Clinical Trial Update: A Study To Assess The Safety And Tolerability Of Different Doses Of PF-06444753 And PF-06444752 In Subjects With Allergic Rhinitis [Phase 1]
This Phase 1 study evaluated the safety and tolerability of different doses of PF-06444753 and PF-06444752 in adults with allergic rhinitis,…
-
CLINICAL_TRIALS research · 2016-06-29Clinical Trial Update: Validation of an Allergic Rhinitis Control Test in Teenagers [NA]
This clinical trial update describes the validation of an Allergic Rhinitis Control Test in teenagers. The current status is unknown.
-
FDA label_change · 2016-06-23FDA Approved: XYZAL — Supplemental Application (Chattem, Inc.)
FDA approved a supplemental application for XYZAL (levocetirizine dihydrochloride) submitted by Chattem, Inc., likely resulting in labeling …
-
CLINICAL_TRIALS trial_result · 2016-06-20Clinical Trial Update: Biological Standarization of Cupressus Arizonica Allergen Extract to Determine the Biological Activity in Histamine Equivalent Units (HEP) [Phase 2]
This Phase 2 study reports efforts to standardize Cupressus arizonica allergen extract and determine its biological activity in histamine-eq…
-
FDA approval · 2016-06-16FDA Approved: CLARINEX — Supplemental Application (Organon LLC)
FDA approved a supplemental application for CLARINEX (desloratadine) submitted by Organon LLC. The action confirms regulatory approval relat…
-
FDA approval · 2016-06-15FDA Approved: CHILDRENS ALLEGRA ALLERGY — Supplemental Application (Chattem, Inc.)
FDA approved a supplemental application for Children's Allegra Allergy (fexofenadine hydrochloride) submitted by Chattem, Inc.
-
FDA approval · 2016-06-10FDA Approved: CHILDRENS ALLEGRA ALLERGY — Supplemental Application (Chattem, Inc.)
FDA approved a supplemental application for Children's Allegra Allergy (fexofenadine hydrochloride) from Chattem, Inc., marking an additiona…
-
FDA approval · 2016-06-02FDA Approved: ALLEGRA-D ALLERGY AND CONGESTION — Supplemental Application (Chattem, Inc.)
The FDA approved a supplemental application for Allegra-D Allergy and Congestion (fexofenadine hydrochloride and pseudoephedrine hydrochlori…
-
FDA approval · 2016-06-02FDA Approved: ALLEGRA-D ALLERGY AND CONGESTION — Supplemental Application (Chattem, Inc.)
The FDA approved a supplemental application for Allegra-D Allergy and Congestion (fexofenadine hydrochloride and pseudoephedrine hydrochlori…
-
FDA approval · 2016-05-31FDA Approved: RYVENT — Original Application (Carwin Pharmaceutical Associates, LLC)
FDA approved Ryvent (carbinoxamine maleate) in relation to its original application for this generic antihistamine from Carwin Pharmaceutica…
-
CLINICAL_TRIALS trial_result · 2016-05-26Clinical Trial Update: Efficacy and Safety of 300 IR Sublingual Immunotherapy (SLIT) Tablets in Children Suffering From Grass Pollen Rhinoconjunctivitis [Phase 3]
Phase 3 trial evaluating the efficacy and safety of a 300 IR grass pollen sublingual immunotherapy tablet in children with grass pollen rhin…
-
FDA approval · 2016-05-26FDA Approved: DESLORATADINE ORAL SOLUTION — Original Application (INA Pharmaceutics, Inc.)
INA Pharmaceutics' Desloratadine oral solution received FDA approval as a generic version of desloratadine for allergic rhinitis and chronic…
-
CLINICAL_TRIALS trial_result · 2016-05-25Clinical Trial Update: Safety and Efficacy on Phase III Study on 300 IR SLIT to Patients Suffering From Grass Pollen Rhinoconjunctivitis [Phase 3]
Phase III trial evaluating the safety and efficacy of a 300 IR grass pollen sublingual immunotherapy (SLIT) for grass pollen rhinoconjunctiv…
-
CLINICAL_TRIALS trial_result · 2016-05-25Clinical Trial Update: Phase III Study to Assess the Long Term Efficacy, Carry-over Effect and Safety of 300 IR Sublingual Immunotherapy Tablets [Phase 3]
Phase III trial assessing the long-term efficacy, carry-over effect, and safety of a 300 IR sublingual immunotherapy tablet for allergy; res…